Optimising immune checkpoint inhibitor therapy in ovarian cancer

Date 15 December 2018
Event ESMO Immuno-Oncology Congress 2018
Session What’s new in breast & gynaecological cancers
Topics Ovarian Cancer
Immunotherapy
Presenter Lana Kandalaft
Authors L. Kandalaft
  • Department Of Oncology, Center Of Experimental Therapeutics, Centre Hospitalier Universitaire Vaudois - CHUV, 1011 - Lausanne/CH